Clinical Trials in Tennessee

Showing 13241-13260 of 17,345 trials

Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma

NCT01908413

This is a phase I, open-label, dose-escalation study of CUDC-427 in patients with advanced or refractory solid tumors or lymphoma. CUDC-427 is a drug that is designed to antagonize proteins that prevent or interfere with cell death. The study is designed to assess the safety, including the maximum tolerated dose, the pharmacokinetics, and the anti-cancer activity of CUDC-427.

Lymphoma

Curis, Inc.23 participantsStarted Jul 2013

Nashville, Tennessee, United States • San Antonio, Texas, United States

Approved For Marketing29 miles

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

NCT00097799

This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.

HIV Infections

Boehringer IngelheimStarted Dec 2004

Anniston, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +112 more locations

Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Find Trials by Condition in Tennessee

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders

Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

Ixabepilone + Carboplatin Metastatic Breast Cancer

Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment

Cladribine in Patients With Mantle Cell Lymphoma

LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer

Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access

Safety of Rt-PA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery

Stimulant Abuser Groups to Engage in 12-Step

Using Stories to Address Disparities in Hypertension

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects